Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27

C Bouchard1, K Thieke, A Maier

  • 1Institute of Molecular Biology and Tumour Research, Phillips-Universität Marburg, Emil-Mannkopff-Strasse 2, 35033 Marburg.

The EMBO Journal
|October 3, 1999
PubMed

Insights

Myc activates cyclin D2 expression, a key step in cell cycle progression. This finding reveals a novel pathway linking Myc to cell division and antagonizing cell cycle inhibitors like p27.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The oncogene Myc drives cell proliferation but its downstream targets remain incompletely understood.
  • Myc's role in regulating cell cycle progression is complex, involving interactions with cyclin-dependent kinases (CDKs) and inhibitors like p27(kip1).

Purpose of the Study:

  • To identify the direct target genes of Myc responsible for inducing cell cycle progression.
  • To elucidate the mechanism by which Myc antagonizes cell cycle inhibitors and promotes cell division.

Main Methods:

  • Analysis of cyclin D2 promoter activity in response to Myc activation.
  • Chromatin immunoprecipitation to assess Myc binding to the cyclin D2 promoter.
  • Functional inhibition of cyclin D2 using p16 or antibodies.
  • Assessment of Myc-induced cell cycle entry, senescence, and apoptosis in cyclin D2-deficient fibroblasts.

Main Results:

  • Myc directly induces cyclin D2 expression by de-repressing its promoter, which is normally repressed by Mad-Max complexes.
  • Cyclin D2 is sequestered by cyclin D2-Cdk4 complexes upon Myc activation, facilitating the dissociation of p27(kip1) from Cdk2.
  • Inhibition of cyclin D2 blocks Myc-induced cell cycle entry and Myc-deficient fibroblasts exhibit accelerated senescence.

Conclusions:

  • Cyclin D2 is a direct downstream effector of Myc, mediating its ability to drive cell cycle progression.
  • This pathway involving Myc, cyclin D2, and p27(kip1) is crucial for overcoming cell cycle arrest and promoting cellular immortalization.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...